Home  >  Products  >  IGF2 (insulin-like growth factor 2 (somatomedin A) ) Blocking Peptide (the C terminal of IGF2)(100ug)
IGF2 (insulin-like growth factor 2 (somatomedin A) ) Blocking Peptide (the C terminal of IGF2)(100ug)

IGF2 (insulin-like growth factor 2 (somatomedin A) ) Blocking Peptide (the C terminal of IGF2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-IGF2 Antibody (ARP54342_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP54342
Size: 100ug
Weight: 25kDa
Gene: 3481
Format: Lyophilized powder
Target: This gene encodes a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumour, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. A read-through INS-IGF2 gene exists, whose 5' region overlaps the INS gene and the 3' region overlaps this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Alternative names: C11orf43; FLJ22066; FLJ44734; INSIGF; pp9974
See Full Product Listings >